Preliminary Scientific Program

SUNDAY, MAY 3, 2009 | MONDAY, MAY 4, 2009 | TUESDAY, MAY 5, 2009 | WEDNESDAY, MAY 6, 2009

SUNDAY, MAY 3, 2009
13:30 – 15:00	Satellite Symposium
15:00 – 15:30	Break

15:30 – 17:00	Satellite Symposium	Hall A
17:00 – 17:30	Break	Hall A

14:00 – 17:30	Lucid Satellite Symposium CONFOCAL MICROSCOPY Chairpersons: G. Pellacani, Italy H. Rabinovitz, USA S. Gonzalez, Spain	Hall B
14:00	WELCOME AND BRIEF HISTORY OF THE CONFOCAL MICROSCOPE S. Gonzalez, Spain
14:10	PRINCIPLES OF CONFOCAL MICROSCOPY I. Klaz, Israel
14:20	TERMINOLOGY A. Scope, USA
14:40	NON –MELANOCYTIC NEOPLASMS A. Rishpon, Israel
14:55	BENIGN MELANOCYTIC NEOPLASMS M. Ulrich, Germany
15:10	MELANOMA G. Pellacani, Italy
15:25	COLLISION TUMORS, LPLK AND MELANOMA ON SUNDAMAGED SKIN IN THE ELDERLY S. Bassoli, Italy
15:40	FLAT PIGMENTED LESIONS OF THE FACE P. Guitera, Australia
15:50	MYCOSIS FUNGOIDES M. Ardigo, Italy
16:00	THE ROLE OF THE PATHOLOGIST WITH CONFOCAL MICROSCOPY M. Gill, USA S. Gonzalez, Spain
16:10	HOW THE CONFOCAL MICROSCOPE IS USED IN A CLINICAL SETTING M. Oliviero, USA
16:25	COMPARISON OF THE CONFIDENCE LEVELS BETWEEN CLINICAL, DERMOSCOPY AND CONFOCAL MICROSCOPY I. Kolm, Austria
16:35 – 17:05	Coffee Break
17:05	UNKNOWNS FOR THE DERMOSCOPY AND CONFOCAL EXPERTS Moderator: H. Rabinovitz, USA Pathologist: M. Gill, USA Expert Dermoscopists: J. Malvehy, Spain S. Puig, Spain Expert Confocalists: A. Scope, USA G. Pellacani, Italy

MONDAY, MAY 4, 2009
08:45 – 10:00	Opening Session	Hall A
08:45	INTRODUCTION / GREETINGS J. Alcalay, Israel P. Robins, USA
09:00	NON-CODING RNA IN SKIN CANCER G. Rechavi, Israel
09:30	THE HUMAN TOPONOME PROJECT: TRANSLATING THE CELLULAR PROTEIN NETWORK CODE INTO EFFICIENT THERAPIES W. Schubert, Germany
10:00 – 10:30	Coffee Break

10:30 – 12:00	PS1: Parallel Session GENETICS OF SKIN CANCER Chairperson: E. Shprecher, Israel	Hall A
10:30	FAMILIAL SKIN CANCER SYNDROMES J. McGrath, UK
11:00	MOLECULAR GENETICS OF BASAL CELL CARCINOMA E. Epstein, USA
11:30	MOLECULAR GENETICS OF SQUAMOUS CELL CARCINOMA P. Boukamp, Germany
12:00	MOLECULAR GENETICS OF MALIGNANT MELANOMA N. Hayward, Australia
12:30 – 14:00	Lunch Break, Exhibition and Poster Viewing

10:30 – 12:00	PS2: Parallel Session PRIMARY AND SECONDARY PREVENTION Chairpersons: H.A. Martino Neumann, The Netherlands D. Henk, Israel	Hall B
10:30	INTRODUCTION H.A. Martino Neumann, The Netherlands
10:40	POPULATION EDUCATION IN PREVENTING SKIN CANCER: FROM CHILD TO ELDERLY E. de Vries, The Netherlands (Tbc)
10:55	IS THERE A PLACE FOR SUN SCREENS? A. Green, Australia (Tbc)
11:10	CHEMOPREVENTION FOR COMPLICATED SUN DAMAGED SKIN D. Askew, Australia
11:25	TOTAL PROGRAMME FROM THE FIRST DIAGNOSIS OF SKIN CANCER E. Stockfleth / C. Ulrich, Germany
11:40	PHOTOBIOLOGY AND PHOTOPROTECTION RESEARCH: HISTORICAL PERSPECTIVES J. Leclaire, France (Tbc)

10:30 – 12:00	PS3: Parallel Session ACTINIC KERATOSIS Chairperson: L.H. Goldberg, USA D. Rozenman, Israel	Hall C
10:30	CLINICAL AND HISTOLOGICAL CORRELATIONS OF EPIDERMAL TUMORS L.H. Goldberg, USA
10:40	TREATMENT OF ACTINIC KERATOSIS WITH CHEMOTHERAPY W.P. Werschler, USA (Tbc)
10:50	TREATMENT OF ACTINIC KERATOSIS WITH PHOTODYNAMIC THERAPY G. Martin, USA
11:00	TREATMENT OF ACTINIC KERATOSIS AND INCIDENCE OF SKIN CANCER J. Cohen, USA
11:10	ACTINIC KERATOSIS AND SKIN DISEASES M. David, Israel (Tbc)
11:20	LASER AND FRACTIONAL LASER RESURFACING TO TREAT ACTINIC KERATOSIS D. Sarnoff, USA
11:30	ACTINIC KERATOSIS AND SQUAMOUS CELL CARCINOMA IN ORGAN TRANSPLANT PATIENTS E. Stockfleth, Germany
11:40	TREATMENT OF ACTINIC KERATOSIS WITH LIQUID NITROGEN B. Kaplan, Israel (Tbc)
11:50	DISCUSSION
12:30 – 14:00	Lunch Break, Exhibition and Poster Viewing

12:30 – 14:00	L'Oreal Satellite Symposium	Hall A
	Program to be confirmed

14:00 – 15:30	PS4: Parallel Session NON-MELANOMA SKIN CANCERS Chairpersons: R. Kaufmann, Germany A. de Silva Picoto, Portugal J. Weiss, Israel	Hall A
14:00	EPIDEMIOLOGY OF NMSC A.J. Stratigos, Greece (Tbc)
14:10	NEW ASPECTS ON CARCINOGENESIS IN NON-MELANOM SKIN CANCERS P. Boukamp, Germany
14:30	IMMUNOSUPPRESSION AND NON-MELANOMA SKIN CANCERS G.M. Murphy, Ireland
14:40	THE POTENTIAL ROLE OF CHEMOPREVENTION IN NON-MELANOMA SKIN CANCERS Tbc
14:55	HOW SHOULD WE BEST TREAT KERATOACANTHOMA? M.H.A. Neumann, The Netherlands
15:10	ACTINIC KERATOSIS, BOWEN’S DISEASE AND ACTINIC CHEILITIS. TREATMENT OPTIONS R. Kaufmann, Germany
15:30 – 16:00	Coffee Break

16:00 – 17:30	PS4: Parallel Session NON MELANOMA SKIN CANCERS (cont)	Hall A
16:00	MELANOCYTES IN EPITHELIAL SKIN TUMORS E.B. Bröcker, Germany
16:20	THE ROLE OF MICROGRAPHIC SURGERY AND SURGICAL DEFECT REPAIR A. de Silva Picoto, Portugal
16:40	MANAGEMENT OF MERKEL CELL CARCINOMA P. Tai, Canada
16:55	THE CURRENT ROLE OF PDT Tbc
17:15	IMMUNE RESPONSE MODIFIERS IN THE TREATMENT OF NON-MELANOMA SKIN CANCERS R. Ruiz-Villaverde, Spain

14:00 – 15:30	PS5: Parallel Session DERMATOPATHOLOGY OF SKIN CANCERS Chairperson: R.P. Rapini, USA A. Gat, Israel	Hall B
14:00	CUTANEOUS LYMPHOMAS: NEW DIAGNOSTIC AND PROGNOSTIC MARKERS H. Kerl, Austria
14:45	THE UNUSUAL HISTOPATHOLOGICAL AND IMMUNOHISTOCHEMICAL VARIANTS OF MYCOSIS FUNGOIDES E. Hodak, Israel
15:30 – 16:00	Coffee Break
16:00 – 17:30	PS5: Parallel Session DERMATOPATHOLOGY OF SKIN CANCERS (cont)
16:00	MELANOMA VERSUS SPITZ NEVUS P.E. Shapiro, USA
16:45	UPDATE ON HISTOPATHOLOGY OF NON-MELANOMA SKIN CANCERS R.P. Rapini, USA

14:00 – 15:30	FC1: Free Communications Chairpersons: A. Ingber, Israel J. Smadja, France	Hall C
15:30 – 16:00	Coffee Break	Hall C

16:00 – 17:30	PS6: Parallel Session SKIN CANCERS IN ORGAN TRANSPLANT RECIPIENTS Chairpersons: T. Stasko, USA I. Zilinski, Israel	Hall C
16:00	INTRODUCTION: REVIEWING THE PROBLEM OF SKIN CANCER IN OTRS T. Stasko, USA
16:05	INSIGHTS FROM GENOMIC ANALYSIS AND THE MICROSCOPIC IMMUNE ENVIRONMENT J. Carucci, USA
16:20	PHOTOPROTECTION IN THE PREVENTION OF SKIN CANCER IN OTRS G.M. Murphy, Ireland
16:35	TOPICAL THERAPIES IN THE PREVENTION OF SKIN CANCER IN OTRS *C. Ulrich, / E. Stockfleth, Germany
16:50	SYSTEMIC THERAPIES IN THE PREVENTION OF SKIN CANCER IN OTRS M. Neuburg, USA
17:05	ALTERATIONS IN IMMUNOSUPPRESSION IN THE PREVENTION OF SKIN CANCER IN OTRS S. Euvrard, France
17:20	EDUCATION OF TRANSPLANT PATIENTS AND TRANSPLANT PROFESSIONALS T. Stasko, USA

17:30	Welcome Reception	Hall C

TUESDAY, MAY 5, 2009
08:00– 10:30	PL1: Plenary Session Chairpersons: A.C. Halpern, USA H. Trau, Israel	Hall A
08:00	XERODERMA PIGMENTOSIUM: IN VITRO MODELS F. Bernerd, France (Tbc)
08:30	MELANOMA D.E. Fisher, USA
09:00	DRUGS THAT CAUSE SKIN CANCER AND DRUGS THAT DON'T M. Lebwohl, USA
09:30	UVR-INDUCED IMMUNOSUPPRESSION AND SKIN CANCER R.D. Granstein, USA
10:00	LIGHT SOURCES AS A TOOL TO PREVENT PHOTOAGING M. Gold, USA
10:30 - 11:00	Coffee Break

11:00 – 12:30	PS7: Parallel Session MELANOMA, DERMATOLOGY Chairpersons: A.C. Halpern, USA J. Rivers, Canada H. Pehamburger, Austria	Hall A
11:00	MELANOMA EPIDEMIOLOGY A.Sober, USA
11:20	MELANOCYTIC TUMOR PROGRESSION D. Elder, USA
11:40	SUN PROTECTION AND MELANOMA PREVENTION P. Autier, France
12:00	MELANOMA GENETICS AND GENETIC TESTING N. Gruis, The Netherlands
12:20	DISCUSSION
12:30 – 14:00	Lunch Break, Exhibition and Poster Viewing

14:00 – 15:30	PS7: Parallel Session MELANOMA, DERMATOLOGY (cont)	Hall A
14:00	NEVOGENESIS AND MELANOMA RISK I. Zalaudek, Austria
14:20	TECHNOLOGIC AIDS TO MELANOMA DIAGNOSIS S. Menzies, Australia
14:40	MANAGEMENT OF LENTIGO MALIGNA K.S. Nehal, USA
15:00	SURGICAL MANAGEMENT OF PRIMARY MELANOMA C. Balch, USA (Tbc)
15:20	DISCUSSION

11:00 – 12:30	PS8: Parallel Session DERMOSCOPY AND IMAGING Chairpersons: S. Menzies, Australia H.S. Rabinovitz, USA N. Nathansohn, Israel	Hall B
	THE MELANOMA FAMILY G. Argenziano, Italy
	PRESENTATION TITLE TBC J. Malvehy, Spain
	DERMOSCOPY OF FULLY REGRESSED CUTANEOUS MELANOMA G. Argenziano, Italy
	PRESENTATION TITLE TBC H.S. Rabinovitz, USA
12:30 – 14:00	Lunch Break, Exhibition and Poster Viewing

14:00 – 15:30	PS8: Parallel Session DERMOSCOPY AND IMAGING (cont)	Hall B
	PRESENTATION TITLE TBC S. Menzies, Australia
	PINK LESIONS I. Zalaudek, Austria
	PRESENTATION TITLE TBC W. Stolz, Germany
	PRESENTATION TITLE TBC S. Puig, Spain
	PRESENTATION TITLE TBC S. Wang , USA
15:30 – 16:00	Coffee Break

16:00 – 17:30	PS8: Parallel Session DERMOSCOPY AND IMAGING (cont)	Hall B
	PRESENTATION TITLE TBC N. Nathansohn, Israel
	PRESENTATION TITLE TBC H. Cabo, Argentina
	PRESENTATION TITLE TBC R. Hoffman-Wellenhof, Austria (Tbc)
	DIGITAL DERMATOSCOPY: INDICATION, BENEFITS AND RISKS H. Kittler, Austria
	PRESENTATION TITLE TBC B. Katz, USA
	PRESENTATION TITLE TBC T.Saida, Japan
	PRESENTATION TITLE TBC V. Ahlgrimm-Siess, Austria

11:00 – 12:30	PS9: Parallel Session NON-SURGICAL TREATMENT FOR NON — MELANOMA SKIN CANCERS Chairpersons: J. Sanchez Conejo-Mir, Spain J. Shiri, Israel	Hall C
11:00	APOPTOSIS BY IMIQUIMOD AND PDT IN NMSC. ARE THE SAME? J. Conejo-Mir, Spain
11:15	UP-DATE OF IMIQUIMOD TREATMENT IN NMSC A. Alomar, Spain
11:30	NEW PERSPECTIVES OF PDT IN NMSC. ASSOCIATED TREATMENTS R.M. Szeimies, Germany
11:45	CHEMICAL PEELINGS AS PREVENTION OF NMSC M. Landau, Israel
12:00	MANAGEMENT STRATEGIES IN TRANSPLANT RECIPIENTS AFFECTED BY NMSC J. Bernabeu-Wittel, Spain
12:15	DISCUSSION
12:30 - 14:00	Lunch Break, Exhibition and Poster Viewing

14:00 – 15:30	PS10: Parallel Session PREVENTION OF SKIN CANCER BY LASERS Chairpersons: M. Lapidoth, Israel M. Adatto, Switzerland	Hall C
14:00	FRACTIONAL RESURFACING FOR PHOTO DAMAGED SKIN AND ACTINIC KERATOSIS C. Dierickx, Belgium (Tbc)
14:15	ABLATIVE FACIAL RESURFACING FOR NONMELANOMA SKIN CANCER PROPHYLAXIS M. Gold, USA (Tbc)
14:30	COMBINATION OF IMIQUIMODE AND FRACTIONAL PHOTOTHERMOLYSIS IN SKIN CANCER PREVENTION M. Lapidoth, Israel
14:45	PDT IN NON MELANOMA SKIN CANCER AND ACTINIC KERATOSIS - AN UPDATE M. Adatto, Switzerland (Tbc)
15:00	IS THERE ANY ROLE FOR LASERS AND LIGHT IN SKIN CANCER MANAGEMENT - A REVIEW R. Barlow, UK (Tbc)
15:15	QUESTIONS & ANSWERS
15:30 – 16:00	Coffee Break

16:00 – 17:30	PS11: Parallel Session SKIN CANCERS IN CHILDHOOD Chairpersons: D. Ben Amitai, Israel A. Zvulunov, Israel	Hall A
16:00	SKIN CANCER PRONE SYNDROMES: DIAGNOSIS AND MANAGEMENT A. Torrelo, Spain
16:20	NEVUS EVOLUTION IN CHILDHOOD: CHANGING PARADIGMS BASED ON LONGITUDINAL STUDIES A. Halpern, USA
16:40	CUTANEOUS T-CELL LYMPHOMA IN CHILDHOOD E. Hodak, Israel
17:00	HYDROA-LIKE CUTANEOUS T-CELL LYMPHOMA IN CHILDHOOD H. Cáceres, Peru
17:20	DISCUSSION

16:00 – 17:30	FC3: Free Communications	Hall C
	Program to be confirmed	Hall C

WEDNESDAY, MAY 6, 2009
08:30 – 10:30	PL2: Plenary Session Chairperson: S. Schneebaum, Israel	Hall A
08:30	SENTINEL LYMPHNODE BIOPSY IN MELANOMA M. Ross, USA
09:10	THE MOLECULAR AND CYTOGENTIC FINDINGS IN MF- TRANSLATING DATA INTO BIOLOGIC AND PRACTICAL MEANING S. Whittaker, UK
09:50	MELANOMA CONTROL M.A. Weinstock, USA
10:30 – 11:00	Coffee Break

11:00 – 12:30	PS12: Parallel Session CUTANEOUS LYMPHOMAS Chairperson: E. Hodak, Israel A. Barzilai, Israel	Hall A
11:00	RECOMMENDATIONS FOR THE STAGING AND TREATMENT OF PRIMARY CUTANEOUS B- CELL LYMPHOMA R. Willemze, The Netherlands
11:30	THE DIFFICULTY IN DRAWING THE LINE BETWEEN CUTANEOUS LYMPHOMA AND PSEUDOLYMPHOMA R. Bergman, Israel
12:00	MYCOSIS FUNGOIDES EPIDEMIOLOGY S. Lessin, USA
12:30 – 14:00	Lunch Break, Exhibition and Poster Viewing

14:00 – 15:30	PS12: Parallel Session CUTANEOUS LYMPHOMAS (cont)	Hall A
14:00	WHAT IS NEW ON THE HORIZON IN THE TREATMENT OF PRIMARY CUTANEOUS T-CELL LYMPHOMA? F. Foss, USA
14:30	THE ROLE OF HEMOPOETIC STEM CELL TRANSPLANTATION IN PRIMARY CUTANEOUS T-CELL LYMPHOMA M. Duvic, USA
15:00	PRIMARY CUTANEOUS LYMPHOMAS IN CHILDHOOD AND ADOLESCENCE E. Hodak, Israel

11:00 – 12:30	PS13: Parallel Session MELANOMA ONCOLOGICAL ASPECTS Chairpersons: M. Lotem, Israel J. Schachter, Israel	Hall B
11:00	THE MOLECULAR BIOLOGY OF MELANOCYTES AND MELANOMA D.E. Fisher, USA
11:30	MELANOMA ASSOCIATED ANTIGENS AS TARGETS OF IMMUNOTHERAPY A. Knuth, Switzerland
12:00	SURGICAL AND SYSTEMIC APPROACHES TO ADJUVANT THERAPY OF MELANOMA A.M.M. Eggermont, The Netherlands
	Lunch Break, Exhibition and Poster Viewing

14:00 – 15:30	PS13: Parallel Session MELANOMA ONCOLOGICAL ASPECTS (cont)	Hall B
14:00	MELANOMA VACCINES - RAISING REALISTIC EXPECTATIONS M. Lotem, Israel
14:20	SYSTEMIC TREATMENT OPTIONS OF MELANOMA Tbc
15:00	ADOPTIVE CELL THERAPY FOR METASTIATIC MELANOMA J. Schachter, Israel

11:00 – 12:30	PS14: Parallel Session MOHS SURGERY	Hall C
	Chairpersons: C. W. Hanke, USA D. J. Leffell, USA
11:00	TECHNIQUES IN MOHS SURGERY L.H. Goldberg, USA
11:12	PREPARATION OF RAPID, LARGE, HIGH QUALITY FROZEN SECTIONS FOR MOHS SURGERY WITH THE CRYOHIST MACHINE C.W. Hanke, USA
11:24	MOHS SURGERY OF SPINDLE CELL TUMORS H.W. Randle, USA
11:36	WHEN MOHS SURGERY FAILS D.J. Leffel, USA
11:48	STAGED EXCISION OF MELANOMA IN SITU WITH RASH FROZEN SECTIONS: 15 YEAR EXPERIENCE M. Neuburg, USA
12:00	MOHS EXPERIENCE WITH UNUSUAL TUMORS T. Stasko, USA
12:12	CHALLENGING MOHS REPAIRS FROM THE USA R. Sengelmann, USA
12:30 – 14:00	Lunch Break, Exhibition and Poster Viewing

14:00 – 15:30	PS15: Parallel Session KAPOSI SARCOMA AND SPINDLE CELL TUMORS Chairperson: R. Bergman, Israel	Hall C
14:00	KAPOSI SARCOMA -AN OVERVIEW R. Bergman, Israel
14:10	INFECTION WITH HUMAN HERPESVIRUS 8 AND THE PATHOGENESIS OF KAPOSI SARCOMA R. Sarid, Israel
14:20	THE BIOLOGY AND EMERGING THERAPIES OF KAPOSI SARCOMA C. Boshoff, UK
14:50	IS THERE STILL A ROLE FOR RADIOTHERAPY IN KAPOSI SARCOMA? A. Kuten, Israel
15:00	SPINDLE CELL TUMORS OF THE SKIN B. Zelger, Austria